Find out how the collaboration between Cobra and Cytiva (formerly GE Life Sciences) has sought to address a growing demand for plasmid DNA.
Cobra Biologics and Watson-Marlow Fluid Technology Group discuss the challenges of vaccine production
The conference focuses on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market
International Society for BioProcess Technology Spring Meeting
Join Cobra at this in-person event to gain actionable insights into the approaches impacting the immunotherapy field
Eva-karin Gidlund, Cobra Collaboration Development Manager, will be attending and speaking at the in-person event this September in Lund.